Control of type II transforming growth factor-β receptor expression by integrin ligation

被引:45
|
作者
Wang, DH
Sun, LZ
Zborowska, E
Willson, JKV
Gong, JG
Verraraghavan, J
Brattain, MG
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Surg, San Antonio, TX 78284 USA
[2] Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78284 USA
[3] Univ Kentucky, Dept Pharmacol, Lexington, KY 40536 USA
[4] Case Western Reserve Univ, Ireland Canc Ctr, Dept Med, Cleveland, OH 44106 USA
[5] Sch Med, Cleveland, OH 44106 USA
[6] Med Coll Ohio, Dept Biochem, Toledo, OH 43699 USA
关键词
D O I
10.1074/jbc.274.18.12840
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ectopic expression of the alpha(5) integrin subunit in cancer cells with little or no endogenous expression of this integrin often results in reduced proliferation as well as reduced malignancy, We now show that inhibition resulting from ectopic expression of alpha(5) integrin is due to induction of autocrine negative transforming growth factor-beta (TGF-beta) activity. MCF-7 breast cancer cells do not express either alpha(5) integrin or type II TGF-beta receptor and hence are unable to generate TGF-beta signal transduction. Ectopic expression of cy,integrin expression enhanced cell adhesion to fibronectin, reduced proliferation, and increased the expression of type II TGF-beta receptor mRNA and cell surface protein. Receptor expression was increased to a higher level in alpha(5) transfectants by growth on fibronectin-coated plates. Induction of type II TGF-beta receptor expression also resulted in the generation of autocrine negative TGF-beta activity because colony formation was increased after TGF-beta neutralizing antibody treatment. Transient transfection with a TGF-beta promoter response element in tandem with a luciferase cDNA into cells stably transfected with cu, integrin resulted in basal promoter activities 5-10-fold higher than those of control cells. Moreover, when alpha(5) transfectants were treated with a neutralizing antibody to either TGF-beta or integrin alpha(5), this increased basal promoter activity was blocked, Autocrine TGF-beta activity also induced 3-fold higher endogenous fibronectin expression in alpha(5) transfectants relative to that of control cells, Re-expression of type II receptor by alpha(5) transfection also restored the ability of the cells to respond to exogenous TGF-beta and led to reduced tumor growth in athymic nude mice. Taken together, these results show for the first time that TGF-beta type II receptor expression can be controlled by alpha(5)beta(1) ligation and integrin signal transduction, Moreover, TGF-beta and integrin signal transduction appear to cooperate in their tumor-suppressive functions.
引用
收藏
页码:12840 / 12847
页数:8
相关论文
共 50 条
  • [41] Transforming growth factor-β type II receptor in pulmonary arteries of patients with very severe COPD
    Beghe, B.
    Bazzan, E.
    Baraldo, S.
    Calabrese, F.
    Rea, F.
    Loy, M.
    Maestrelli, P.
    Zuin, R.
    Fabbri, L. M.
    Saetta, M.
    EUROPEAN RESPIRATORY JOURNAL, 2006, 28 (03) : 556 - 562
  • [42] Expression of transforming growth factor-β1 and its type Ⅰ receptor in autogenous vein grafts in rats
    孙达欣
    ChinaMedicalAbstracts, 2005, (03) : 170 - 171
  • [43] Expression of transforming growth factor-α in hepatoblastoma
    Kiss, A
    Szepesi, A
    Lotz, G
    Nagy, P
    Schaff, Z
    CANCER, 1998, 83 (04) : 690 - 697
  • [44] Interaction between the transforming growth factor-β type II receptor/Smad pathway and β-catenin during transforming growth factor-β1-mediated adherens junction disassembly
    Tian, YC
    Phillips, AO
    AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (05): : 1619 - 1628
  • [45] Stimulation of the murine type II transforming growth factor-β receptor promoter by the transcription factor Egr-1
    Wilder, PJ
    Bernadt, CT
    Kim, JH
    Rizzino, A
    MOLECULAR REPRODUCTION AND DEVELOPMENT, 2002, 63 (03) : 282 - 290
  • [46] EXPRESSION OF THE TYPE-II TRANSFORMING GROWTH-FACTOR-BETA RECEPTOR IN THE INTESTINE
    WINESETT, MP
    RAMSEY, GW
    BARNARD, JA
    GASTROENTEROLOGY, 1994, 106 (04) : A640 - A640
  • [47] Mechanism of induction of transforming growth factor-β type II receptor gene expression by v-Src in murine myeloid cells
    Park, SH
    Birchenall-Roberts, MC
    Yi, YS
    Lee, BI
    Lee, DK
    Bertolette, DC
    Fu, T
    Ruscetti, F
    Kim, SJ
    CELL GROWTH & DIFFERENTIATION, 2001, 12 (01): : 9 - 18
  • [48] Receptor expression modulates the specificity of transforming growth factor-β signaling pathways
    Murakami, Masaru
    Kawachi, Hiroyuki
    Ogawa, Kenji
    Nishino, Yoshii
    Funaba, Masayuki
    GENES TO CELLS, 2009, 14 (04) : 469 - 482
  • [49] Effects of diabetes and hypertension on glomerular transforming growth factor-β receptor expression
    Kang, MJ
    Ingram, A
    Ly, H
    Thai, K
    Scholey, JW
    KIDNEY INTERNATIONAL, 2000, 58 (04) : 1677 - 1685
  • [50] Enhanced hepatocyte growth factor signaling by type II transforming growth factor-β receptor knockout fibroblasts promotes mammary tumorigenesis
    Cheng, Nikki
    Chytil, Anna
    Shyr, Yn
    Joly, Alison
    Mosesi, Harold L.
    CANCER RESEARCH, 2007, 67 (10) : 4869 - 4877